ArticleFrontiers in bioengineering and biotechnology2022

An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy.

Chuang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.